Verteporfin Photodynamic Therapy for the Treatment of Choroidal Conditions—An Overview
Jaycob Avaylon, Ron P Gallemore
US Ophthalmic Review, 2019;12(2):69–78
Photodynamic therapy (PDT) is a technique involving the use of a photosensitizing agent that, when activated by light of a specific wavelength, causes localized and selective tissue damage.1,2 Initially developed to treat tumor cells using tumor-localizing photosensitizing agents (e.g., Photofrin®, Pinnacle Biologics, Chicago, IL USA),1 ophthalmic PDT was developed in the 1990s to treat conditions such as […]